QA: Kronos Bio Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001741830_2023_Kronos_Bio_Inc.pdf

Logs

Graph

Absolute values for 0001741830, Kronos Bio Inc.

  xvar xval
0 AssetsCurrent 244,291,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,985,000
3 remainder_Assets 37,662,000
4 LiabilitiesCurrent 21,486,000
5 LiabilitiesNoncurrent 28,953,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,400,000
9 ResearchAndDevelopmentExpense 93,715,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,911,000
13 remainder_ComprehensiveNetIncome -753,000
  yvar yval
0 Assets 294,938,000
1 Liabilities 50,439,000
2 Expenses 137,115,000
3 Revenues 0
4 StockholdersEquity 244,499,000
5 NetIncome -133,204,000
6 ComprehensiveNetIncome -133,580,500
7 BaseVar 243,578,000
8 EconomicCapitalRatio 1.66

Edgar->Model Mapping

Feature Distribution

Change over Time